Cardiol Therapeutics (CRDL.TO) Q3 2024 Earnings

15AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.14
-0.13
-0.11
-0.1

Details

Expected EPS
-0.141928983608885
Actual EPS
-0.1003506845
Surprise EPS
0.04
Surprise Percent
+29.3%

Description

Cardiol Therapeutics (CRDL.TO) has reported earnings of -0.1003506845 per share for Q3 2024.

0 Comments

Share your thoughts